Grant: Planning and Dissemination Grants - Institute/Initiative Community Support
University of British Columbia
$20,000.00
Defining new research questions for bleeding disorders and thrombosis
EF 2026-27
Résumé
Blood clotting disorders (such as hemophilia) are a major health threat due to the inability to form life-saving blood clots. However, blood clots that form inappropriately (thrombosis) lead to heart attacks and strokes. We still don't fully understand how clotting works and what drives bleeding disorders at the molecular level. For better treatments, we must understand how our blood cells communicate, or "signal" with each other and with other cells in our bodies. This workshop will bring together key groups of leaders who will have a unique chance to discuss the latest evidence on these subjects - physicians, scientists, and patients - to exchange critical knowledge on this subject. Together, we will identify improved research questions and design better studies that will help the many people suffering from life- threatening bleeding and cardiovascular disorders.
Programme
Planning and Dissemination Grants - Institute/Initiative Community Support
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
571709
Name
Kim Hugh
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Planning and Dissemination Grants
Projecttitle
Defining new research questions for bleeding disorders and thrombosis
Programtype2
Miscellaneous Programs
Orgnameinp2
University of British Columbia
Cihramount2
$20,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grants - Institute/Initiative Community Support
Keyworddelim
Atherothrombosis; Bleeding Disorders; Blood; Cardiovascular Health; Coronary Disease; Myocardial Infarction; Stroke; Thrombosis
Abstract
Blood clotting disorders (such as hemophilia) are a major health threat due to the inability to form life-saving blood clots. However, blood clots that form inappropriately (thrombosis) lead to heart attacks and strokes. We still don't fully understand how clotting works and what drives bleeding disorders at the molecular level. For better treatments, we must understand how our blood cells communicate, or "signal" with each other and with other cells in our bodies. This workshop will bring together key groups of leaders who will have a unique chance to discuss the latest evidence on these subjects - physicians, scientists, and patients - to exchange critical knowledge on this subject. Together, we will identify improved research questions and design better studies that will help the many people suffering from life- threatening bleeding and cardiovascular disorders.
Competitiondate
202606
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kim, Hugh
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $20,000~ $0~